The global actinic keratosis market is estimated to be valued at USD 8.73 Bn in 2024 and is expected to exhibit a CAGR of 4.9% during the forecast period (2024-2031). Actinic keratosis is a precancerous skin condition caused by prolonged exposure to UV radiation from the sun. It is characterized by scaly or crusty patches that develop on sun-exposed areas like the face, lips, ears, bald scalp, forearms, the back of the hands, and lower lips. These patches are caused by the abnormal and uncontrolled growth of keratinocytes in the upper layer of the epidermis. If left untreated, actinic keratosis has the potential to develop into squamous cell carcinoma, a type of skin cancer. Rising awareness regarding skin health and early diagnosis has been driving the global actinic keratosis market growth.
Market Dynamics:
The global actinic keratosis market is primarily driven by the increasing prevalence of the condition owing to sun exposure. Prolonged and unprotected exposure to ultraviolet radiation is the main risk factor for actinic keratosis. With rising outdoor recreational activities and occupational sun exposure, the demand for effective treatment and management options is steadily increasing. Additionally, favorable reimbursement policies for treatment procedures and increasing approval of new treatment modalities are providing impetus to the market growth. However, high cost of branded drugs remains a key challenge. Ongoing research into new formulations with better efficacy and reduced treatment duration can help overcome this challenge and further create growth opportunities in the global actinic keratosis market.
Key Features of the Study:
Detailed Segmentation-
Company Profiles:
Table of Contents
*Browse 32 market data tables and 28 figures on "Actinic Keratosis Market” - Global forecast to 2031
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients